Absolutely agree. The fact that Elite has both a generic business and an ADF pipeline is fantastic when compared to the huge majority of pure R&D companies that only do R&D.
They should be touting aspects of their pipeline such as their QDaily ADF Oxycodone/Naltrexone candidate. If they could make progress on that, it would be awesome.
News 
Market Data 
Discover 
AI
